The world started with a ‘bang' but will end in a scary ‘big crunch' — and scientists think they know when that will be
Now, according to astrophysicists and cosmologists, Earth and all of its celestial siblings will likely be swallowed back into the super-small singularity they came from, in what is known as the 'big crunch' theory.
Alarming as it sounds, physicists say there's no reason to fret just yet.
According to leading experts on the matter, the big crunch theory supposes that the universe will eventually stop expanding and everything will be pulled back together.
Cosmologists at Cornell University predict that the big crunch is billions of years away —19.5 to be exact.
Henry Tye, a lead researcher at the institution, suggested that the big crunch will begin in 11 billion years, and will take another 8.5 billion years to conclude.
Supposing humanity is still around billions of years from now, scientists say it's unlikely we would notice any distinct changes while the big crunch takes place.
'Intelligent civilizations at the scales of solar systems or even galactic scales would not notice any obvious phenomenon because these changes happen at much larger cosmological scales,' Dr Hoang Nhan Luu, a researcher at the Donostia International Physics Center, explained to the Daily Mail.
However, one of the warning signs would be a rising cosmic temperature.
In a few billion years, it's probable that the universe, including all of its major celestial bodies, will be the same temperature as the surface of the sun.
'Needless to say, all humans will burn up in the furnace of this cosmic hell,' Avi Loeb, an astrophysicist at Harvard University, told the Daily Mail.
The theory has been swirling among academic circles for decades, but fell out of favor among some camps of researchers several decades back.
However, after dark energy — a repellent force that pushes things in the universe apart — was discovered in the '90s and research has progressed, it seems more and more experts are reevaluating their stances.
Mustapha Ishak-Boushaki, an astrophysicist at the University of Texas at Dallas, told Discover Magazine that dark matter research has revealed that the universe isn't slowing down, but rather, its expansion is accelerating less, and eventually, it will come to a slow halt.
'To survive, human beings have to move to the edge of our solar system or beyond. We have a few billion years' time to prepare for that trip,' Tye explained to the Daily Mail.
The big crunch theory spells trouble for humanity in several ways, but it's far from the first scary-sounding phenomenon that our planet has undergone.
Earth's magnetic poles reversed 780,000 years ago. Researchers at the Helmholtz Centre for Geosciences in Germany created a soundscape of the geological gymnastics routine, which they dubbed a 'disharmonic cacophony.'
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Aptar's First Nasal Pump Made with 52% Bio-based Material* now Available with Haleon's Otrivin® Brand
The Freepod® nasal spray pump, globally used with the Otrivin® brand, is now made from 52% bio-based feedstock CRYSTAL LAKE, Ill., July 29, 2025--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery and active material science solutions and services, is proud to announce that its Freepod® nasal spray pump - one of the delivery systems for Haleon's Otrivin® brand - is now made with mass balance bio-based resins. This is the first Aptar delivery system using such materials to be commercialized globally. The use of more sustainable renewable plastic resources is a meaningful measure to help reduce the use of fossil-based materials in healthcare primary packaging. Reinforcing circularity in pharmaceutical packaging Aptar Pharma's Freepod® spray pump used with Haleon's Otrivin® Nasal Spray is made of 52% ISCC Plus certified bio-based feedstock. The bottle is produced using a mass balance approach equivalent to 100% bio-based content. Together, the pump and bottle components result in an overall circular material content of 60% for the full nasal spray device. ISCC PLUS certified manufacturing and supply chain Aptar Pharma is committed to helping its customers meet their sustainability goals, such as reducing the use of fossil-based materials in packaging. The Freepod® nasal spray components are made from bio-based resins derived from renewable feedstocks like bio-waste and residual oils, using an ISCC PLUS-certified mass balance approach. The Aptar Pharma manufacturing site in Mezzovico, Switzerland, is ISCC PLUS certified, ensuring full traceability of materials throughout the manufacturing process and supply chain. ISCC Plus certification also covers all external suppliers - including injection molding providers, service partners, and warehouses - guaranteeing a fully (ISCC) certified supply chain for the Freepod® components. Partnership for a more sustainable approach The joint sustainability approach between Haleon (formerly GSK Consumer Healthcare) and Aptar Pharma is built on a long-term partnership spanning over 30 years. This collaboration has led to significant achievements, including the Otrivin® Freepod® winning the World Packaging Award in 2019 for its innovative and sustainable design. The use of bio-based or renewable feedstocks for the Otrivin® products with Freepod® technology supports Haleon's goal to reduce virgin petroleum-based plastic use by 10% by 2025** and by a third by 2030, compared to 2022 levels. Aptar Pharma's Freepod® for Otrivin®, available globally, demonstrates Aptar's commitment to sustainability and innovation. Looking ahead, this collaboration is anticipated to extend to Otrivin Nasal Mist, Haleon's latest microdroplet technology, which is being rolled out globally since 2023. "At Aptar, sustainability is not just a responsibility - it's a strategic advantage," commented Gael Touya, President of Aptar Pharma. "The launch of Freepod® Futurity™ reflects our commitment to developing solutions that respond to consumers' increasing demand for more sustainable healthcare delivery technologies. As a trusted partner to Haleon, we are proud to help drive the success of the Otrivin® brand while enabling a shift away from fossil-based materials in primary packaging. Supporting our partners in reaching their environmental goals reinforces our vision of supporting the healthcare industry, from Formulation to patient." With a strong commitment to sustainability, Aptar Pharma continuously strives to reduce its environmental impact and support its partners in achieving their sustainability goals. *ISCC Plus certified bio-based feedstock, mass balance approach.**The end point for the goal delivery period is the end of the 2025 calendar year. About Aptar Pharma Aptar Pharma is part of AptarGroup, Inc. (NYSE:ATR), a global leader in the design and manufacturing of a broad range of drug delivery, consumer product dispensing and active material science solutions. Aptar's innovative solutions and services serve a variety of end markets including pharmaceutical, beauty, personal care, home, food and beverage. Using insights, proprietary design, engineering and science to create dispensing, dosing and protective technologies for many of the world's leading brands, Aptar in turn makes a meaningful difference in the lives, looks, health and homes of millions of patients and consumers around the world. Aptar is headquartered in Crystal Lake, Illinois and has over 13,000 dedicated employees in 20 countries. For more information, visit About Haleon Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding. View source version on Contacts Media Contact: Ciara JacksonAptar Pharma+49 151 1951
New York Times
22 minutes ago
- New York Times
I Left a Plastic Water Bottle in a Hot Car. Is It Safe to Drink?
Q: If I leave a plastic water bottle in my car for a few days, is it safe to drink the water when I come back? It's important to stay hydrated in the heat, but high temperatures and UV rays can influence what goes on in single-use plastic water bottles — especially when they have been sitting in cars, where windows can trap extra heat. Scientists warn that chemical additives and microplastics could leach into the water, and that bacteria or mold could grow in the bottle. Does that make the water unsafe to drink? We asked experts to help us sort it out. Microbes in the Water One potential concern is that if you've already opened a plastic bottle and have consumed water from it, bacteria from your mouth, your hands or the air can get in and multiply, said Jaime Ross, a neuroscientist at the University of Rhode Island who studies how exposures to microplastics and other substances affect the body. Beizhan Yan, a geochemist who researches environmental contamination at Columbia University, said he wasn't aware of any studies that have looked into exactly what happens if you leave a plastic water bottle in a hot car. But scientists can make inferences from relevant research. In one peer-reviewed study published in 2013, for instance, researchers analyzed which microbes grew in various partly consumed beverages — including plastic bottled sodas, teas, juices, sports drinks and water — left at 77 degrees for two weeks. They found that bacteria, mold and yeast grew in many of them. Want all of The Times? Subscribe.
Washington Post
22 minutes ago
- Washington Post
‘I'm not a politician,' says NIH director. But it's not that simple.
'I'm not a politician,' the new director of the National Institutes of Health, Jay Bhattacharya insists. 'I'm not going to get involved in the political fight over things.' Easier said than done. The great challenge facing the former Stanford University doctor and economist as he guides the world's largest public funder of biomedical research is that science and American politics have become intertwined as perhaps never before. There is little ideological distance between NIH headquarters in Bethesda, Maryland, and the White House in nearby D.C.
